MergerLinks Daily Review

MergerLinks Daily Review

Welcome to MergerLinks Daily Review. Sign up here to get the full round up of your daily dose of blue-chip M&A news directly to your inbox.

EQT completed the acquisition of Perficient for $3bn. (Financial Sponsors)

Clearlake Capital and Francisco Partners completed the acquisition of Software Integrity Group from Synopsys for $2.1bn. (FS)

CyberArk completed the acquisition of Venafi from Thoma Bravo for $1.54bn. (FS)

Sanofi is said to ask bidders to revise consumer health offers.

Greece's HFSF narrows National Bank share sale price range.

You can access today’s complete newsletter here.

Scroll down for more…


EQT Group , a private equity firm, completed the acquisition of Perficient, a digital consultancy, for $3bn.

“Today, Perficient begins an exciting new chapter – one that is focused exclusively on executing our long-term, global growth strategy. For more than 25 years, we have developed long-term, trusted partnerships with many of the world’s biggest brands, which would not have been possible without our global team of 7,000 strategists, designers, technologists and engineers. EQT further strengthens our ability to focus on innovation and expansion, grow our talent around the world, and forge a stronger future with and for our customers,” Tom Hogan, Perficient President and CEO.

Perficient was advised by 美国银行 , 富国银行 , Kirkland & Ellis (led by Sarkis Jebejian and Rachael Coffey ), and? Joele Frank (led by Lynch, Tim ). Financial advisors were advised by Cleary Gottlieb Steen & Hamilton LLP (led by Paul Shim ). EQT was advised by J.P. 摩根 , TD Securities , Simpson Thacher & Bartlett LLP (led by Elizabeth Cooper ).


Clearlake Capital and Francisco Partners completed the acquisition of Software Integrity Group from Synopsys for $2.1bn. (FS)

Private equity firms Clearlake Capital Group and Francisco Partners completed the acquisition of Software Integrity Group, an application security testing software provider, from 新思科技 , an American electronic design automation company, for $2.1bn.

"As security becomes more embedded in DevOps workflows, we believe the demand and importance of application security testing providers will continue to rise. We are ready to leverage Clearlake's O.P.S.? framework to foster operational enhancements, build upon the Software Integrity Group's robust product offering, and fuel new growth as a standalone enterprise," Behdad Eghbali, Clearlake Co-Founder and Managing Partner.

Clearlake Capital was advised by Barclays , 德意志银行 , Evercore , Bredin Prat (led by José Maria Pérez ), Sidley Austin LLP (led by Mehdi Khodadad and Nicolai Schwarz-Gondek ), Simpson Thacher & Bartlett LLP (led by Robert Langdon ), Lambert (led by Jennifer Hurson ) and Sloane & Company (led by Whit Clay ). Synopsys was advised by J.P. 摩根 , Cleary Gottlieb Steen & Hamilton LLP (led by Christopher Moore ), 博然思维集团 and FGS Global (led by John Christiansen ).


CyberArk completed the acquisition of Venafi from Thoma Bravo for $1.54bn. (FS)

CyberArk , the identity security company, completed the acquisition of Venafi, a CyberArk Company , a provider of machine identity management, from Thoma Bravo , a private equity firm, for $1.54bn.

"This acquisition marks a pivotal milestone for CyberArk, enabling us to further our vision to secure every identity – human and machine – with the right level of privilege controls," Matt Cohen, CyberArk CEO.

Venafi was advised by 奥睿 (led by Shawn Atkinson ). CyberArk was advised by 摩根士丹利 and Latham & Watkins (led by Joshua Kiernan , Leah Sauter and Josh Dubofsky ). Thoma Bravo was advised by Piper Sandler , Kirkland & Ellis (led by Brad Reed and Corey Fox ) and FGS Global (led by Elizabeth Micci ). TCV was advised by Weil, Gotshal & Manges LLP (led by Kyle Krpata ).


Sanofi is said to ask bidders to revise consumer health offers.

Sanofi has asked bidders to revise their proposals for its consumer health unit, as it considers whether to seek a sale or listing of the business, Bloomberg reported.

The French company asked suitors to submit revised bids for the Opella business in the coming days. The request gives bidders the chance to either improve their proposals or provide additional clarity on specific terms under negotiation.


Greece's HFSF narrows National Bank share sale price range.

The price range for an offer of National Bank of Greece shares has been narrowed to between €7.40 ($7.95) and €7.65 ($8.22) per share, Reuters reported.

HFSF is selling a 10% stake in Greece's second largest bank by market value through a book-building process and a public offer in Greece which end on October 2. The offering was oversubscribed by more than 11 times by late October 1.

Interested to find more? Sign up here to get full round up of your daily dose of blue-chip M&A news directly to your inbox.

You can access today’s complete newsletter here.

要查看或添加评论,请登录

MergerLinks的更多文章

社区洞察

其他会员也浏览了